These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2883648

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Closure of a high-output external pancreatic fistula by SMS 201-995, a long-acting analogue of somatostatin.
    de Bois MH, Bosman CH, de Graaf P, van Hoogenhuijze J.
    Neth J Med; 1988 Jun; 32(5-6):293-7. PubMed ID: 2899299
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of pancreatic cutaneous fistulas with a somatostatin analog.
    Prinz RA, Pickleman J, Hoffman JP.
    Am J Surg; 1988 Jan; 155(1):36-42. PubMed ID: 2893556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Somatostatin analogues and pancreatic fistulas.
    Bassi C, Falconi M, Caldiron E, Bonora A, Salvia R, Pederzoli P.
    Digestion; 1996 Jan; 57 Suppl 1():94-6. PubMed ID: 8813483
    [Abstract] [Full Text] [Related]

  • 7. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression.
    Rosenberg L, Dafoe DC, Schwartz R, Campbell DA, Turcotte JG, Tsai ST, Vinik A.
    Transplantation; 1987 May; 43(5):764-6. PubMed ID: 2883747
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas].
    Brunaud L, Sebbag H, Marchal F, Verdier A, Bresler L, Tortuyaux JM, Boissel P.
    Ann Chir; 2001 Feb; 126(1):34-41. PubMed ID: 11255969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.
    Ahrén B, Tranberg KG, Bengmark S.
    Br J Surg; 1988 Jul; 75(7):718. PubMed ID: 2901281
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibition of exocrine pancreatic function by somatostatin?].
    Jung D, Düben W, Lux M, Heymann H.
    Z Gastroenterol; 1986 Mar; 24(3):161-2. PubMed ID: 2871669
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of external pancreatic fistula by depot somatostatin].
    Faroux R, Bretagne JF, Le Jean-Colin I, Loreal O, Darnault P, Gastard J.
    Presse Med; 1986 Mar; 16(28):1379. PubMed ID: 2888105
    [No Abstract] [Full Text] [Related]

  • 15. The use of a somatostatin analog in the treatment of an external pancreatic fistula.
    Turner JW.
    Mo Med; 1994 Dec; 91(12):737-9. PubMed ID: 7854311
    [Abstract] [Full Text] [Related]

  • 16. Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience.
    Bassi C, Falconi M, Salvia R, Caldiron E, Butturini G, Pederzoli P.
    Langenbecks Arch Surg; 2000 Jan; 385(1):10-3. PubMed ID: 10664113
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
    Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM.
    Can J Gastroenterol; 2004 May; 18(5):303-6. PubMed ID: 15152279
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites.
    Grauer L, Barkin JS.
    Digestion; 1994 May; 55 Suppl 1():24-8. PubMed ID: 7907566
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.